CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 1,281.00
-60.00 (-4.47%)
Feb 19, 2026, 1:50 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 103.12 billion as of February 18, 2026. Its market cap has decreased by -41.95% in one year.
Market Cap
103.12B
Enterprise Value
157.41B
Revenue
18.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,281.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 103.12B, a decrease of -24.95%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 103.12B | -9.82% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| Macrogen | 195.80B |
| ENCell | 183.11B |
| GeneOne Life Science | 140.58B |
| IMB Dx | 114.53B |
| iNtRON Biotechnology | 112.35B |